Table of Contents
ToggleOverview of CLL Chronic lymphocytic leukaemia (CLL) is a cancer that affects a specific type of white blood cells called lymphocytes. It develops slowly and is most commonly diagnosed in people over the age of 60, rarely affecting individuals younger than 40, and almost never children.
In CLL, the bone marrow produces an excessive number of lymphocytes that are not fully developed and don’t function properly, leading to various health issues. Over time, this can cause a higher susceptibility to infections, fatigue, swollen lymph nodes, and abnormal bleeding or bruising.
CLL is distinct from other types of leukaemia, such as chronic myeloid leukaemia (CML), acute lymphoblastic leukaemia (ALL), and acute myeloid leukaemia (AML).
Symptoms of CLL CLL often does not cause symptoms in its early stages and may only be detected during routine blood tests. When symptoms do occur, they can include:
If you experience persistent or concerning symptoms, it’s important to see your GP. These symptoms could be caused by conditions other than cancer, but it is always best to have them evaluated.
Treatments for CLL Since CLL progresses slowly and may not cause immediate symptoms, treatment might not be necessary right away if the condition is detected early. Instead, regular monitoring through check-ups over months or years may be recommended to track any changes.
When symptoms develop or the disease advances, treatment options may include:
While CLL is not usually curable, treatment can slow its progression and induce symptom-free periods. Treatment may be repeated if CLL returns.
Outlook for CLL The prognosis for CLL depends on factors such as the stage at diagnosis, age, and overall health. Generally, younger and healthier individuals diagnosed at an early stage have a more favorable outlook. While complete cure is uncommon, treatment can help manage and control the disease over many years.
Causes of CLL The exact cause of CLL is not well understood, and it has not been linked to radiation, chemicals, diet, or infections. It is not contagious and cannot be passed from person to person.
Certain genetic factors may increase the risk of developing CLL. Having a close family member with the condition may slightly increase your risk, although it remains relatively low overall.
Initial Steps in Diagnosis Chronic lymphocytic leukaemia (CLL) is often detected through routine blood tests conducted for other medical reasons. However, if you experience symptoms such as persistent tiredness, unusual bleeding or bruising, unexplained weight loss, or night sweats, you should consult your GP. Your GP may:
Referral to a Specialist If your GP suspects CLL, you will be referred to a haematologist—a doctor specializing in blood disorders—who will conduct further tests to confirm the diagnosis.
The primary diagnostic test for CLL is a full blood count. This involves checking the number and appearance of different blood cells in a laboratory. An abnormally high count of atypical white blood cells (lymphocytes) often indicates CLL. Analyzing these cells under a microscope can help confirm the diagnosis and provide important information about the progression of the disease.
To better understand how CLL is affecting your body, the following imaging tests may be recommended:
In some cases, a bone marrow biopsy may be performed. This procedure involves:
In certain instances, a lymph node biopsy may be required. This involves:
Your blood and bone marrow samples may also be tested for genetic abnormalities in cancerous cells. Identifying unusual genes can help doctors determine:
Treatment for chronic lymphocytic leukaemia (CLL) depends on the stage of the disease at diagnosis. Many people may not require immediate treatment if the condition is detected early. However, for more advanced stages, treatments such as chemotherapy are often necessary. While treatment can help control CLL for extended periods, it may not cure it completely. Remission may occur after initial treatment, but the disease often returns and may require additional treatment.
Doctors classify CLL into three main stages, which helps determine the need for treatment:
Stage B and C CLL generally require immediate treatment, while Stage A usually needs treatment only if the condition worsens or starts causing symptoms.
If there are no symptoms at diagnosis:
Most patients eventually require chemotherapy to control the cancer. Treatment typically involves:
Alternative Medicines: If these medications are unsuitable or ineffective, options include bendamustine, chlorambucil, ibrutinib, idelalisib, obinutuzumab, ofatumumab, and prednisolone.
Common side effects include:
Notify your care team if you experience side effects, as they may offer treatment or adjustments to help.
Stem cell transplants may help achieve prolonged control or remission:
Additional options include:
Choosing not to undergo certain treatments due to potential side effects affecting quality of life is a personal decision. If you opt out of a specific treatment, pain relief and supportive care will still be available.
Before making any treatment decisions, speak with your doctor and consider involving your family or friends. You’ll be given time to make informed choices about managing CLL.
Chronic lymphocytic leukaemia (CLL) can sometimes lead to various complications, affecting overall health and quality of life. Here are the key complications associated with CLL:
People with CLL often have a weakened immune system, making them more vulnerable to infections due to a reduced number of healthy, infection-fighting white blood cells. Chemotherapy treatment can further suppress immune function.
Managing Infection Risk:
In about 1 in 20 people with CLL, the disease can transform into an aggressive type of non-Hodgkin lymphoma, known as Richter’s transformation or Richter’s syndrome.
Symptoms of Richter’s Syndrome Include:
Treatment: Usually involves intensive chemotherapy combined with other medications. More detailed information is available through resources like Cancer Research UK.
Approximately 1 in 10 people with CLL may develop autoimmune haemolytic anaemia, a condition where the immune system attacks and destroys red blood cells, leading to severe anaemia.
Symptoms of Anaemia:
Treatment: Typically managed with steroid medications to suppress immune system activity against red blood cells.
Being diagnosed with CLL can be emotionally challenging, especially since it often cannot be cured, and treatment may involve long waiting periods before active management. These circumstances can lead to stress, anxiety, and depression.
Coping with Psychological Effects:
Living with CLL involves ongoing management and support. By staying informed about potential complications and being proactive in seeking care and emotional support, you can better manage the challenges of the condition.
The exact cause of chronic lymphocytic leukaemia (CLL) is not fully understood. However, researchers have identified several factors that may increase the likelihood of developing the condition. Below is a summary of these risk factors:
In some instances, CLL appears to run in families. This suggests a potential inherited genetic mutation that may increase susceptibility to developing the disease. More research is necessary, but having a parent or sibling with CLL slightly raises your risk of also developing the condition.
CLL is more prevalent among people of European, American, and Australian origin and less common in individuals from China, Japan, and Southeast Asia. The reason for these ethnic differences is not well understood, but studies show that CLL is more frequent in white populations than in black or Asian populations.
Certain medical conditions may slightly elevate your risk of developing CLL. These conditions include:
Some of these conditions may occur due to lowered immunity, which can happen during the early stages of CLL, rather than directly causing it. Additionally, having a weakened immune system, such as due to HIV/AIDS or taking immunosuppressive medications after an organ transplant, may also increase your risk of developing CLL.
While exposure to radiation has been linked to an increased risk of other types of leukaemia, there is no conclusive evidence connecting radiation exposure specifically to CLL.
Men are approximately twice as likely to develop CLL compared to women, for reasons that are not entirely understood. The risk of developing CLL also increases with age; it is most commonly diagnosed in individuals over the age of 60.
The Cancer Research UK website provides additional information about risk factors associated with CLL. If you are concerned about your risk, speaking with a healthcare professional can help you better understand your susceptibility and options for monitoring or reducing potential risks.